sapropterin dihydrochloride

Generic: sapropterin dihydrochloride

Labeler: endo usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name sapropterin dihydrochloride
Generic Name sapropterin dihydrochloride
Labeler endo usa, inc.
Dosage Form POWDER, FOR SOLUTION
Routes
ORAL
Active Ingredients

sapropterin dihydrochloride 500 mg/1

Manufacturer
ENDO USA, Inc.

Identifiers & Regulatory

Product NDC 49884-873
Product ID 49884-873_d7b2a60c-b7ac-4353-af15-8f0c5fafd172
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210027
Listing Expiration 2026-12-31
Marketing Start 2020-10-01

Pharmacologic Class

Classes
breast cancer resistance protein inhibitors [moa] p-glycoprotein inhibitors [moa] phenylalanine hydroxylase activator [epc] phenylalanine hydroxylase activators [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49884873
Hyphenated Format 49884-873

Supplemental Identifiers

RxCUI
1653217
UPC
0349884873721
UNII
RG277LF5B3

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sapropterin dihydrochloride (source: ndc)
Generic Name sapropterin dihydrochloride (source: ndc)
Application Number ANDA210027 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 30 PACKET in 1 CARTON (49884-873-72) / 1 POWDER, FOR SOLUTION in 1 PACKET (49884-873-52)
source: ndc

Packages (1)

Ingredients (1)

sapropterin dihydrochloride (500 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d7b2a60c-b7ac-4353-af15-8f0c5fafd172", "openfda": {"upc": ["0349884873721"], "unii": ["RG277LF5B3"], "rxcui": ["1653217"], "spl_set_id": ["2e13a3b5-e4df-4d5c-9b26-02a7006a7c3e"], "manufacturer_name": ["ENDO USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PACKET in 1 CARTON (49884-873-72)  / 1 POWDER, FOR SOLUTION in 1 PACKET (49884-873-52)", "package_ndc": "49884-873-72", "marketing_start_date": "20201001"}], "brand_name": "SAPROPTERIN DIHYDROCHLORIDE", "product_id": "49884-873_d7b2a60c-b7ac-4353-af15-8f0c5fafd172", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Phenylalanine Hydroxylase Activator [EPC]", "Phenylalanine Hydroxylase Activators [MoA]"], "product_ndc": "49884-873", "generic_name": "SAPROPTERIN DIHYDROCHLORIDE", "labeler_name": "ENDO USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SAPROPTERIN DIHYDROCHLORIDE", "active_ingredients": [{"name": "SAPROPTERIN DIHYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA210027", "marketing_category": "ANDA", "marketing_start_date": "20201001", "listing_expiration_date": "20261231"}